Micrographia Bio
Entrepreneur First '20London, GB · Founded 2020 · 4 known investors
Micrographia Bio pairs imaging mass spectrometry with AI analysis to map how proteins are distributed across tissue samples at cellular resolution. Drug developers use the resulting spatial proteomics data to identify potential therapeutic targets and study mechanisms of action.
Biotech
Founders & leadership
Micrographia Bio was founded in 2020 by Julia Li and Chris Thompson.
JL
Julia LiinCEOJulia Li earned a PhD in Engineering as a Gates Cambridge Scholar, researching novel financing mechanisms for global health. Building on that work, she created, fundraised for and deployed a $108 million global health investment fund alongside Lion's Head Global Partners and the Bill and Melinda Gates Foundation, the first of its kind.
CT
Chris ThompsoninCTOChris Thompson holds a Master's in Microbiology from the University of Louisville and a PhD in Microbial Pathogenesis from Imperial College London. After a period in academic cancer research, he moved into industry as a machine learning engineer at a startup.
Investors · 4
Frequently asked questions
- What does Micrographia Bio do?
- Micrographia Bio pairs imaging mass spectrometry with AI analysis to map how proteins are distributed across tissue samples at cellular resolution. Drug developers use the resulting spatial proteomics data to identify potential therapeutic targets and study mechanisms of action.
- Who founded Micrographia Bio?
- Micrographia Bio was founded by Julia Li, Chris Thompson in 2020.
- Who are Micrographia Bio's investors?
- Micrographia Bio's investors include DCVC (Data Collective), Entrepreneur First, Samos Investments, Ada Ventures.
- Where is Micrographia Bio headquartered?
- Micrographia Bio is headquartered in London, GB.